Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

Nordestgaard, Børge G., Langlois, Michel R., Langsted, Anne, Chapman, M. John, Aakre, Kristin M., Baum, Hannsjörg, Borén, Jan, Bruckert, Eric +21 more·2020·Atherosclerosis
DOI 10.1016/j.atherosclerosis.2019.12.005

Cited by (228)

Items 101–200 of 228

  1. Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol
    Pieter-Jan Briers, Michel R. Langlois · 2022 · University of Zagreb University Computing Centre (SRCE)
  2. Remnant cholesterol, vascular risk, and prevention of atherosclerosis
    Xavier Pintó, Marta Fanlo‐Maresma, Virginia Esteve-Luque, Jesús Millán · 2023 · Clínica e Investigación en Arteriosclerosis (English Edition)
  3. When to lower triglycerides?
    Om P. Ganda · 2020 · Current Opinion in Lipidology
  4. Effects of diets rich in ghee or olive oil on cardiometabolic risk factors in healthy adults: a two-period, crossover, randomised trial
    Susan Mohammadi Hosseinabadi, Javad Nasrollahzadeh · 2021 · British Journal Of Nutrition
  5. Risk Factors of Recurrence of Acute Pancreatitis: A Retrospective Research
    Kun Song, Cuirong Guo, Changluo Li, Ning Ding · 2021 · The Turkish Journal of Gastroenterology
  6. Risk-weighted apoB: a novel summary metric outperforming traditional lipid biomarkers in predicting coronary heart disease
    Michaela Beatrice Rehman, Elias Björnson, Martin Adiels, Jakub Morze, Göran M.L. Bergström, Anders Gummesson, David Erlinge, Tove Fall, Ljubica Perisic Matic, Stefan Söderberg et al. · 2026 · European Heart Journal
  7. Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world
    Dana J. Murdock, Keran Moll, Robert J. Sanchez, Jing Gu, Sergio Fazio, Gregory P. Geba, Fátima Rodríguez · 2024 · American Journal of Preventive Cardiology
  8. Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible?
    Pier Luigi Temporelli, Marcello Arca, Laura D’Erasmo, Raffaele De Caterina · 2021 · Journal of Clinical Medicine
  9. Closing the gaps in patient management of dyslipidemia: stepping into cardiovascular precision diagnostics with apolipoprotein profiling
    Esther Reijnders, Arnoud van der Laarse, L. Renee Ruhaak, Christa M. Cobbaert · 2024 · Clinical Proteomics
  10. Prevalence and status of Lipoprotein (a) among Lebanese school children
    Marie‐Hélène Gannagé‐Yared, Christina Lahoud, Nada Younès, Rima Chédid, Ghassan Sleilaty · 2020 · Scientific Reports
  11. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should a basic lipid profile include?
    Teresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruíz, Manuel Rodríguez Piñero, Josέ Francisco Valderrama Marcos, Antonio Pérez, Manuel Antonio Botana López, Ana Moráis López, José Antonio García Donaire, Juan Carlos Obaya et al. · 2023 · Neurology Perspectives
  12. Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE study
    Miriam Pikkemaat, Mark Woodward, Peder af Geijerstam, Stephen B. Harrap, Pavel Hamet, Giuseppe Mancia, Michel Marre, Neil R Poulter, John Philip Chalmers, Katie Harris · 2024 · Diabetes Obesity and Metabolism
  13. Saturated fatty acids and total and CVD mortality in Norway: a prospective cohort study with up to 45 years of follow-up
    Erik Arnesen, Ida Laake, Marit Bragelien Veierød, Kjetil Retterstøl · 2024 · British Journal Of Nutrition
  14. High Density Lipoproteins: Is There a Comeback as a Therapeutic Target?
    Arnold von Eckardstein · 2021 · Handbook of experimental pharmacology
  15. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
    Teresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruíz, Manuel Rodríguez Piñero, Josέ Francisco Valderrama Marcos, Antonio M. Botana López, Ana Moráis López, José Antonio García Donaire, Juan Carlos Obaya, Luis Castilla Guerra et al. · 2023 · Nefrología (English Edition)
  16. Disconnect between triglyceride reduction and cardiovascular outcomes: lessons from the PROMINENT and CLEAR Outcomes trials
    Lale S Tokgözoğlu, Angela Pirillo, Alberico Luigi Catapano · 2023 · European Heart Journal
  17. Approach to risk stratification of atherosclerotic cardiovascular disease
    Daniel Esau, Beth L. Abramson · 2022 · Canadian Family Physician
  18. Lipoprotein(a) and Familial Hypercholesterolemia: A Short Review Including the Laboratory Viewpoint
    Masato Hamasaki, Kazuhiko Kotani · 2020 · Cardiology Research
  19. Study on the prediction model of atherosclerotic cardiovascular disease in the rural Xinjiang population based on survival analysis
    Xin Qian, Mulatibieke Keerman, Xianghui Zhang et al. · 2023 · BMC Public Health
  20. Assessment of three equations to calculate plasma LDL cholesterol concentration in fasting and non-fasting hypertriglyceridemic patients
    Joséphine Vasse, Audrey Lassartesse, Oriane Marmontel, Sybil Charrière, Caroline Bouveyron, Nathanaël Marrié, Philippe Moulin, Mathilde Di Filippo · 2023 · Clinical Chemistry and Laboratory Medicine (CCLM)
  21. Effects of dietary enzymatically treated Artemisia annua L. in low fish meal diet on growth, antioxidation, metabolism and intestinal health of Micropterus salmoides
    Xiaofang Dai, Shujie Zhu, Jingwei Ye, Qiaoqing Xu, Tilin Yi, Chenglong Wu, Benjun Wang, Kai Luo, Weihua Gao · 2023 · Aquaculture Reports
  22. Prospects for the Use of Sialidase Inhibitors in Anti-atherosclerotic Therapy
    Igor Alexandrovich Sobenin, Alexander M. Markin, Victor Yu. Glanz, Yuliya V. Markina, Wei‐Kai Wu, Veronika A. Myasoedova, Alexander Nikolaevich Orekhov · 2020 · Current Medicinal Chemistry
  23. Prevention starts from the crib: the pediatric point of view on detection of families at high cardiovascular risk
    Maria Elena Capra, Cristina Pederiva, Giuseppe Banderali, Giacomo Biasucci · 2021 · The Italian Journal of Pediatrics/Italian journal of pediatrics
  24. Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association for Laboratory Medicine
    Julia S. Kenkre, Tina Mazaheri, R. Dermot G. Neely, Handrean Soran, Dev Borunendra Nath Datta, Peter Edward Penson, Paul Downie, Alexandra M Yates, Katharine Hayden, Mayur Patel et al. · 2025 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
  25. Reducing LDL-Cholesterol to Very Low Levels: Sailing Between Established Benefits and Potential Risks
    Stefania Angela Di Fusco, Massimo Volpe, Federico Nardi, Andrea Matteucci, Stefano Aquilani, G. Marino, Alessandro Aiello, Furio Colivicchi · 2025 · High Blood Pressure & Cardiovascular Prevention
  26. Effect of Adding Apolipoprotein B Testing on the Prevalence of Dyslipidemia and Risk of Cardiovascular Disease in the Korean Adult Population
    Rihwa Choi, Sang Gon Lee, Eun Hee Lee · 2024 · Metabolites
  27. Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes
    Montse Guardiola, Pere Rehues, Núria Amigó, Francisco Arrieta, Manuel Botana, José Antonio Gimeno-Orna, Josefa Girona, José Ignacio Martínez‐Montoro, Emilio Ortega, Antonio Pérez et al. · 2024 · European Journal of Clinical Investigation
  28. HDL cholesterol efflux capacity and cholesterol loading capacity in long-term fasting: Evidence from a prospective, single-arm interventional study in healthy individuals.
    F. Grundler, M. Palumbo, M. Adorni, F. Zimetti, B. Papotti, Dietmar Plonné, Alfred Holley, R. Mesnage, M. Ruscica, Françoise Wilhelmi de Toledo · 2024 · Atherosclerosis
  29. Effect of high-fat diet and morning or evening exercise on lipoprotein subfraction profiles: secondary analysis of a randomised trial
    Trine Tegdan Moholdt, Evelyn B. Parr, Brooke L. Devlin, Guro Fanneløb Giskeødegård, John Alan Hawley · 2023 · Scientific Reports
  30. Optimum lipid testing for diabetic patients to enhance clinical care
    Sridevi Devaraj, Ishwarlal Jialal · 2021 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  31. Secular trends in serum lipid profiles in young adults in Norway, 2001-19
    Erik Arnesen, Kjetil Retterstøl · 2022 · Atherosclerosis Plus
  32. Assessment of Low LDL Cholesterol in Patients Treated by PCSK9 Inhibition: Comparison of Martin/Hopkins and Friedewald Estimations
    Aya Egbaria, Walid Saliba, Barak Zafrir · 2020 · Cardiovascular Drugs and Therapy
  33. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles
    Teresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruíz, Manuel Rodríguez Piñero, Josέ Francisco Valderrama Marcos, Antonio Pérez, Manuel Antonio Botana López, Ana Moráis López, José Antonio García Donaire, Juan Carlos Obaya et al. · 2023 · Clínica e Investigación en Arteriosclerosis
  34. Burden of lipoprotein(a) for patients with atherosclerotic cardiovascular disease: A retrospective analysis from the United States
    Ana Filipa Fonseca, Hannah Byrne, Andrés Laguna-Fernández, Taha Itani, Rachel L. Studer, Jihaeng Heo, Allison Dillon, Philippe C. Ferber, Madlaina Costa‐Scharplatz · 2023 · Journal of Managed Care & Specialty Pharmacy
  35. Effects of sitagliptin on serum lipid levels in patients with type 2 diabetes: a systematic review and meta-analysis
    Li‐Da Wu, Nan Zhou, Jin-Yu Sun, Hao Yu, Ruxing Wang · 2021 · Journal of Cardiovascular Medicine
  36. Chronotype, Lifestyles, and Anthropometric and Biochemical Indices for Cardiovascular Risk Assessment Among Obese Individuals
    M. Alexandre, Rui Poínhos, CRI-O Group, Bruno M. P. M. Oliveira, Flora Correia · 2025 · Nutrients
  37. Gender-specific correlations between remnant cholesterol and severe abdominal aortic calcification in American adults
    Laisha Yan, Xiaoyan Hu, Shanshan Wu, Shunying Zhao · 2024 · Frontiers in Endocrinology
  38. Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: what parameters should a basic lipid profile include?
    Teresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruíz, Manuel Rodríguez Piñero, Josέ Francisco Valderrama Marcos, Antonio Pérez, Antonio M. Botana López, Ana Moráis López, José Antonio García Donaire, Juan Carlos Obaya et al. · 2023 · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
  39. Elevated ApoB/apoA-1 is Associated with in-Hospital Mortality in Elderly Patients with Acute Myocardial Infarction
    Yan Chen, Shengyue Chen, Yuanyuan Han · 2023 · Diabetes Metabolic Syndrome and Obesity
  40. Relationship between LDL-cholesterol, small and dense LDL particles, and mRNA expression in a cohort of African Americans
    Ana Francisca Diallo, Malak Abbas, Gabriel A. Goodney, Elvin T. Price, Amadou Gaye · 2024 · American Journal of Physiology-Heart and Circulatory Physiology
  41. Current concept and residual issues of lipoprotein(a) determination for a cardiovascular risk factor
    Hiroshi Yoshida, Yuji Hirowatari, Masatsune Ogura, Mariko Harada‐Shiba · 2021 · European Journal of Clinical Investigation
  42. Association of non-HDL-C/apoB ratio with long-term mortality in the general population: A cohort study
    Kerui Zhang, Chenchen Wei, Yaqing Shao, Wang Li, Zongquan Zhao, Yin Song, Xuejun Tang, Yuan Li, Zhongshan Gou · 2024 · Heliyon
  43. Opinion paper: Is the Friedewald equation obsolete?
    Ishwarlal Jialal, William E. Winter · 2020 · Clinica Chimica Acta
  44. Friedewald, Martin/Hopkins ou Sampson/NIH: Qual o Melhor Método para Estimar o LDL-Colesterol?
    Fernando Yue Cesena · 2022 · Arquivos Brasileiros de Cardiologia
  45. Metabolic profile in women with bulimia nervosa or binge-eating disorder before and after treatment: secondary analysis from the randomized PED-t trial
    Therese Fostervold Mathisen, Jorunn Kaiander Sundgot-Borgen, Jan Harald Rosenvinge · 2023 · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
  46. Cumulative remnant cholesterol burden increases the risk of cardiovascular disease among young adults
    Yi Wang, Yijun Zhang, Xiaonan Wang, Shuohua Chen, Xue Tian, Qin Xu, Xue Xia, Shouling Wu, Fen Liu, Anxin Wang · 2024 · Annals of Epidemiology
  47. Superior prognostic value of estimated small dense LDL cholesterol for cardiovascular risk assessment: evidence from international cohort studies
    Yichen Ma, Xiaobing Zhai, Danni Mu · 2025 · Lipids in Health and Disease
  48. Modern approaches to screening diagnostics of the risk of metabolic syndrome based on integrated clinical and laboratory indicators (review)
    Galina Aleksandrovna Bezrukova, Tamara Anatolievna Novikova, Anatoliy Nikolaevich Mikerov · 2022 · Sanitarnyj vrač (Sanitary Doctor)
  49. Comparative performance of equations to estimate low‐density lipoprotein cholesterol levels and cardiovascular disease incidence: The ATTICA study (2002–2022)
    Tzortzis Nomikos, Michael Georgoulis, Christina A. Chrysohoou, Evangelia Damigou, Fotios Barkas, Ioannis Skoumas, Evangelos N. Liberopoulos, Christos S. Pitsavos, Costas P. Tsioufis, Petros Paul Sfikakis et al. · 2023 · Lipids
  50. Labordiagnostik von Fettstoffwechselstörungen
    Winfried März, Hubert Scharnagl, Marcus Edi Kleber, Günther Silbernagel, Matthias Nauck, Dirk Müller‐Wieland, Arnold von Eckardstein · 2023 · DMW - Deutsche Medizinische Wochenschrift
  51. A bibliometric analysis and visualization of literature on non-fasting lipid research from 2012 to 2022
    Yilin Hou, Zehua An, Xiaoyu Hou, Yunpeng Guan, Guangyao Song · 2023 · Frontiers in Endocrinology
  52. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles
    Teresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruíz, Manuel Rodríguez Piñero, Josέ Francisco Valderrama Marcos, Antonio Pérez, Manuel Antonio Botana López, Ana Moráis López, José Antonio García Donaire, Juan Carlos Obaya et al. · 2023 · REC CardioClinics
  53. Exploring Utilization and Establishing Reference Intervals for the Apolipoprotein B Test in the Korean Population
    Rihwa Choi, Sang Gon Lee, Eun Hee Lee · 2023 · Diagnostics
  54. Establishing Apolipoprotein-B and non-high-density-lipoprotein-C goals in Indian population: A Cross-sectional study
    Parul Berry, Ritvik Amarchand, Lakshmy Ramakrishnan, Ruby Gupta, Dimple Kondal, Vishwesh M. Bharadiya, Anand Krishnan, Nikhil Tandon, Dorairaj Prabhakaran, Ambuj Roy · 2024 · Indian Heart Journal
  55. Impact of a personalized, strike early and strong approach on non-HDL-cholesterol levels and outcome in patients with acute myocardial infarction
    Giuseppe Patti, Luca Cumitini, Manuel Bosco, Alessandra Marengo, Domenico D’Amario, Marco Giovanni Mennuni, Martina Solli, Leonardo Grisafi · 2025 · International Journal of Cardiology
  56. Consensus document on the role of plasma triglycerides in cardiovascular disease from the Italian Society for the Study of Atherosclerosis (SISA)
    Alberto Zambon, Luigi Gentile, Federica Galimberti, Enzo Manzato, Andrea Giaccari, Giorgio Sesti, Anna Belfiore, Giuseppe Danilo Norata, Pier Luigi Temporelli, Luca Frulloni et al. · 2025 · Nutrition Metabolism and Cardiovascular Diseases
  57. Comparison of novel LDL cholesterol equations in myocardial infarction patients: Clinical impact on risk re-classification and lipid treatment goals on secondary prevention
    Georgios K. Chalikias, Levent Serif, Adina Thomaidis, Asimina Lantzouraki, Dimitrios Stakos, Dimitrios N. Tziakas · 2020 · Atherosclerosis
  58. Evolución 2001-2018 de los niveles de colesterol sérico en una población de Cataluña (Osona, Barcelona)
    Joan Deniel Rosanas, J. Prat Quinzaños, Pere Roura Poch · 2021 · Atención Primaria Práctica
  59. Chylomicronemia Due to the Rare Hyperlipoproteinemia Type 3 Complicated by a Circulating Monoclonal Protein
    Hiba Basheer, Beheshteh Nakhaee, Ishwarlal Jialal · 2021 · Laboratory Medicine
  60. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles: ¿Qué parámetros debe incluir un perfil lipídico básico?
    Teresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruíz, Manuel Rodríguez Piñero, Josέ Francisco Valderrama Marcos, Antonio Pérez, Manuel Antonio Botana López, Ana Moráis López, José Antonio García Donaire, Juan Carlos Obaya et al. · 2023 · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
  61. Lipoprotein(a) and Effects of Diet: Time for Reassessment
    Byambaa Enkhmaa, Lars Berglund · 2025 · Nutrients
  62. Further advices on measuring lipoprotein(a) for reducing the residual cardiovascular risk on statin therapy
    Giuseppe Lippi, Giovanni Targher · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)
  63. Diabetic dyslipidaemia
    Khosrow Adeli, Changting Xiao, Victoria Higgins, Jennifer Taher, Sarah Farr, Gary F. Lewis · 2021 · Elsevier eBooks
  64. Implantación de un programa de cribado bioquímico y genético de hipercolesterolemia familiar. Colaboración entre el laboratorio clínico y las unidades de lípidos: diseño del Proyecto ARIAN
    Teresa Arrobas Velilla, Ángel Brea, Pedro Valdivielso et al. · 2021 · Clínica e Investigación en Arteriosclerosis
  65. Residual Cardiovascular Risk Factors in Dyslipidemia
    Van Si Nguyen, Xuan Truong Tran, Thanh Duy Vo, Quang Truong Cao Le · 2021 · IntechOpen eBooks
  66. Cholesterol measurement and current guidelines
    Vladimír Soška · 2022 · Vnitřní lékařství
  67. LDL cholesterol burden in elderly patients with familial hypercholesterolemia: Insights from real-world data
    Torunn Melnes, Martin Prøven Bogsrud, Jacob Juel Christensen, Amanda Rundblad, Kjetil Retterstøl, Ingunn Narverud, Pål Aukrust, Bente Lise Halvorsen, Stine Marie Ulven, Kirsten Bjørklund Holven · 2025 · American Journal of Preventive Cardiology
  68. Update on genetics of familial hypercholesterolemia
    Tomáš Freiberger · 2026 · Current Opinion in Lipidology
  69. Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics
    Christian Bork, Børge Grønne Nordestgaard, Berit Storgaard Hedegaard, Michal Vrablik, Elsie Evans, Tomáš Freiberger, Zlatko Fras, David Nanchen, Fouzia Sadiq, Kausik Kumar Ray et al. · 2026 · Atherosclerosis
  70. Effect of lipoprotein (a) on the analytical determination of low-density lipoprotein cholesterol (LDLc) and its influence on pharmacological treatment with atorvastatin
    Aida Navarro, José Manuel Cabezas-Agrícola, Fernando Jesús Hermida · 2022 · Scandinavian Journal of Clinical and Laboratory Investigation
  71. Status of lipid profile tests according to the last consensus paper
    Burak Arslan, İdil Melis Çobanoğlu, Aylin Sepici Dinçel · 2020 · Turkish Journal of Biochemistry
  72. Clinical reasoning and prevention of cardiovascular disease
    Allan D. Sniderman, Michael J. Pencina, George Thanassoulis · 2021 · Journal of clinical lipidology
  73. Lipoproteína (a) es un factor predictor de no consecución de objetivos de C-LDL en pacientes con cardiopatía isquémica crónica
    José Javier Gómez-Barrado, Paula Gómez-Turégano, María Beltran-Moreno, A.I. Fernández-Chamorro, Benjamín Roque Rodríguez, Zineb Kounka · 2024 · Clínica e Investigación en Arteriosclerosis
  74. Examine low-density lipoprotein, remnants, and lipoprotein(a) in parallel in high risk patients
    Martin Bødtker Mortensen, Børge Grønne Nordestgaard · 2020 · European Heart Journal
  75. Acercamiento a los síndromes de hipertrigliceridemia: la importancia de distinguir entre etiologías primaria y secundaria
    Ivette Cruz‐Bautista · 2021 · Cardiovascular and Metabolic Science
  76. Triglycerides, Triglyceride-Rich Lipoproteins, and High-Density Lipoprotein in Coronary Heart Disease Risk Assessment
    Anne Tybjærg‐Hansen, Børge Grønne Nordestgaard · 2023 · Elsevier eBooks
  77. Mass-spectrometric analysis of APOB polymorphism rs1042031 (G/T) and its influence on serum proteome of coronary artery disease patients: genetic-derived proteomics consequences
    Muneeza Zafar, Imran Riaz Malik, Munazza Raza Mirza, Fazli Rabbi Awan, Arkadiusz Nawrocki, Misbah Hussain, Haq Nawaz Khan, Shahid Abbas, Muhammad Iqbal Choudhary, Martin R. Larsen · 2023 · Molecular and Cellular Biochemistry
  78. Lipids, Lipoproteins, and Cardiovascular Outcomes
    Alexander P. Sakers, Reed Mszar, Daniel E. Soffer · 2024 · Contemporary cardiology
  79. Rethinking atherogenic risk: is apolipoprotein B a better biomarker?
    Giuseppe Lippi · 2026 · Clinical Chemistry and Laboratory Medicine (CCLM)
  80. Development and Analytical Validation of a Multiplex LC-MRM-MS–Based Reference Measurement Procedure for Apolipoprotein A-I and Btotal Quantification in Serum
    Nina M. Diederiks, Fred P.H.T.M. Romijn, Nicolaas J.M. van Neer, Mervin Pieterse, Julia Dittrich, Uta Ceglarek, Christa M. Cobbaert, L. Renee Ruhaak, the IFCC Working Group for Standardization of Apolipoproteins by Mass Spectrometry, L. Renee Ruhaak et al. · 2026 · Clinical Chemistry
  81. Hyperlipoproteinemia(a) and Severe Coronary Artery Lesion Types
    Larisa N. Ilina, Olga I. Afanasieva, Andrey A. Shiryaev, Власова Элина Евгеньевна, Курбанов Саид Курбанович, Marina I. Afanasieva, Ежов Марат Владиславович, Vladislav P. Vasiliev, Галяутдинов Дамир Мажитович, Sergei N. Pokrovsky et al. · 2022 · Biomedicines
  82. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles
    Teresa Arrobas, Carlos Guijarro, Raquel Campuzano, Manuel Rodríguez Piñero, Josέ Francisco Valderrama Marcos, Antonio M. Botana López, Ana Moráis López, José Antonio García Donaire, Juan Carlos Obaya, Luis Castilla Guerra et al. · 2023 · Revista Clínica de Medicina de Familia
  83. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories
    Teresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruíz, Manuel Rodríguez Piñero, Josέ Francisco Valderrama Marcos, Antonio Pérez, Manuel Antonio Botana López, Ana Moráis López, José Antonio García Donaire, Juan Carlos Obaya et al. · 2023 · Clínica e Investigación en Arteriosclerosis (English Edition)
  84. Consensus document for lipid profile testing and reporting in Spanish clinical laboratories
    Teresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruíz, Manuel Rodríguez Piñero, Josέ Francisco Valderrama Marcos, Antonio Pérez, Manuel Antonio Botana López, Ana Moráis López, José Antonio García Donaire, Juan Carlos Obaya et al. · 2023 · Revista Clínica Española (English Edition)
  85. Grundlagen einer sex- und gendersensiblen Diagnose und Therapie
    Vera Regitz‐Zagrosek · 2023 · Springer eBooks
  86. The year 2019 in Atherosclerosis
    Christoph J. Binder, Jan Borén, Alberico Luigi Catapano, Geesje M. Dallinga‐Thie, Florian Kronenberg, Ziad Mallat, Simona Negrini, Paolo Raggi, Arnold von Eckardstein · 2020 · Atherosclerosis
  87. Variabilité de la triglycéridémie : impact métabolique. De la dysfonction du tissu adipeux à l’adiposité viscérale et à la stéatopathie métabolique, les chemins de l’insulino-résistance
    Olivier Ziegler · 2022 · Médecine des Maladies Métaboliques
  88. Approche de la stratification du risque de maladies cardiovasculaires athéroscléreuses
    Daniel Esau, Beth L. Abramson · 2022 · Canadian Family Physician
  89. Exploring non-high-density lipoprotein estimation methods and their clinical significance in cardiovascular disease
    Pallavi B. Hangargekar, Deepak Kumar Jha, Md Akbar . · 2023 · Advance Pharmaceutical Journal
  90. Reporting LDL cholesterol results by clinical biochemistry laboratories in Czechia and Slovakia to improve the detection rate of familial hypercholesterolemia
    Michal Vrablı́k, Veronika Šálková, Marek Vecka, Vladimír Soška, Marek Budina, Tomáš Šálek · 2023 · Biochemia Medica
  91. Erratum to: Conducting Clinical Trials in Heart Failure During (and After) the COVID-19 Pandemic: An Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
    2021 · European Heart Journal
  92. Special Issue on “Advances in Cholesterol and Lipid Metabolism”
    Allison Bethanne Reiss, Joshua De Leon · 2022 · Metabolites
  93. HDL markers in cardiovascular risk prediction: Ethnicity matters
    Jane K. Stock · 2020 · Atherosclerosis
  94. Сoagulation hemostasis indices after hemorrhagic stroke, developed as a complication of essential hypertension
    Oleksandr V. Tkachyshyn · 2021 · ScienceRise Medical Science
  95. Survey on lipid diagnostics in Italy from the Working Group on Myocardial Markers (GdS MM) of the Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL): results and recommendations for reporting
    Massimiliano Luca Manno, Piero Cappelletti, Marco Moretti, Elisabetta Stenner, Francesca Veneziani, Maria Aurora Burgio, Martina Di Pietro, Margherita Morandini, Giulio Marino, Jessica VIOLA et al. · 2021 · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine
  96. Evidence for Beneficial Associations between Isoenergetic Macronutrient Exchanges and Serum non-HDL Cholesterol, a Measure of All Circulating Atherogenic, apoB-Containing Lipoproteins
    Bruce Arthur Griffin, Julie Anne Lovegrove · 2021 · Journal of Nutrition
  97. Apolipoproteína B: sus ventajas en el manejo del riesgo cardiovascular aterosclerótico
    Raúl Ignacio Coniglio · 2021 · Redalyc (Universidad Autónoma del Estado de México)
  98. Population-Based Nutrition Epidemiology
    Demosthenes B. Panagiotakos · 2021 · MDPI eBooks
  99. Hypertriglyceridaemia: a commentary
    Aidan Ryan, William G Simpson, Patrick J. Twomey · 2022 · Journal of Clinical Pathology
  100. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles
    Teresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruíz, Manuel Rodríguez Piñero, Josέ Francisco Valderrama Marcos, Antonio Pérez, Manuel Antonio Botana López, Ana Moráis López, José Antonio García Donaire, Juan Carlos Obaya et al. · 2023 · Hipertensión y Riesgo Vascular